Literature DB >> 11775433

Gallbladder cancer.

L G Dawes1.   

Abstract

Gallbladder cancer often presents with advanced disease. When found early, surgery can be curative for this particular malignancy. Prognostic factors that influence the success of aggressive surgical therapy include depth of invasion, extent of hepatic infiltration, histologic grade, presence of venous, lymphatic or perineural invasion, and lymph node metastasis. Tumors with tumor limited to the subserosal layer, hepatic infiltration that is only 5 mm or less, papillary or well differentiated adenocarcinomas, tumors with no venous, lymphatic or perineural invasion and lymph node metastasis limited to the hepatoduodenal ligament have the best prognosis with surgery (15, 16, 36). Extended cholecystectomy with lymph node dissection has improved the results of treating T2 gallbladder cancers. More extensive resections should keep the above prognostic factors in mind. When surgical resection is not possible, endoscopic stenting of the biliary tree for palliation of obstructive jaundice is effective. Earlier detection or more effective chemotherapy will be needed to significantly improve the prognosis of this disease.

Entities:  

Mesh:

Year:  2001        PMID: 11775433     DOI: 10.1007/978-1-4757-3371-6_8

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  3 in total

1.  Significance of epithelial growth factor in the epithelial-mesenchymal transition of human gallbladder cancer cells.

Authors:  Takamitsu Sasaki; Hiroki Kuniyasu; Yi Luo; Daisuke Kato; Satoshi Shinya; Kiyomu Fujii; Hitoshi Ohmori; Yuichi Yamashita
Journal:  Cancer Sci       Date:  2012-04-03       Impact factor: 6.716

2.  Consecutive instances of gallstone ileus due to obstruction first at the ileum and then at the duodenum complicating a gallbladder carcinoma: a case report.

Authors:  R Zissin; A Osadchy; E Klein; F Konikoff
Journal:  Emerg Radiol       Date:  2005-12-14

3.  Expression of homeodomain protein CDX2 in gallbladder carcinomas.

Authors:  Xiang-Song Wu; Yoshimitsu Akiyama; Toru Igari; Tohru Kawamura; Susumu Hiranuma; Toshikatsu Shibata; Kouji Tsuruta; Morio Koike; Shigeki Arii; Yasuhito Yuasa
Journal:  J Cancer Res Clin Oncol       Date:  2005-01-11       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.